Pharmaceutical

Biocon’s Denosumab biosimilars gain EU marketing author...

Biocon Biologics’ Denosumab biosimilars, Vevzuo and Evfraxy, have received marke...

Brii Biosciences and Joincare sign licence agreement fo...

Brii Biosciences and Joincare Pharmaceutical have signed a licence and technolog...

Merck concludes SpringWorks acquisition for $3.4bn

Merck KGaA has concluded the previously announced acquisition of SpringWorks The...

Cell and gene therapy: The vital role of logistics

By 2030, the cell and gene therapy market is projected to be worth £76.03bn, and...

Navigating the AI regulatory maze: Why 91% of life scie...

Life science professionals must navigate a complex regulatory maze to implement ...

Podcast: The importance of Social Determinants of Healt...

A new podcast from industry experts MarketScan explains why social determinants ...

FDA approves Dizal’s Zegfrovy to treat adults with NSCLC

Dizal has received FDA approval for Zegfrovy to treat adults with locally advanc...

Protecting patients’ data is vital for NHS single healt...

The UK Government is pushing for a single, unified digital patient record within...

Analysis shows Yeztugo approval a ‘momentous step’ for ...

Analysis shows Gilead’s recently approved drug for HIV prevention, Yeztugo, has ...

Sanofi agrees to invest $25m in Adagene

Sanofi is to invest up to $25m in Adagene, which will enable the latter to fund ...

Trump tax bill estimated to cut Medicaid spend by $1trn...

US President Donald Trump’s One Big Beautiful Bill Act (H.R. 1) has narrowly pas...

Vertex wins European approval for Alyftrek, bolstering ...

With its blockbuster Trikafta set to lose patent protection within the decade, V...

Sobi gains FDA approval for Gamifant to treat HLH/MAS

The FDA has approved Sobi's Gamifant (emapalumab) to treat adults and children w...

Torrent Pharmaceuticals to acquire stake in JB Pharma f...

Torrent has signed definitive agreements to acquire stake in JB Pharma at an equ...

US trade tariffs and the potential impact on pharma sup...

As the pharma sector braces for sector-specific tariffs from President Trump, wh...

Vetter breaks ground on $285m US clinical manufacturing...

Vetter Pharma, has begun the construction of a new clinical manufacturing facili...